These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 18557745

  • 21. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B, Pita L, Gomes S, Gonçalves J, Faustino P.
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [Abstract] [Full Text] [Related]

  • 22. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E, Kuek C, Beilby JP, Jeffrey GP, Devine A, Prince RL.
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [Abstract] [Full Text] [Related]

  • 23. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM.
    N Engl J Med; 2008 Jan 17; 358(3):221-30. PubMed ID: 18199861
    [Abstract] [Full Text] [Related]

  • 24. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
    Barton JC, Leiendecker-Foster C, Reboussin DM, Adams PC, Acton RT, Eckfeldt JH, Hemochromatosis and Iron Overload Screening Study Research Investigators.
    Thyroid; 2008 Aug 17; 18(8):831-8. PubMed ID: 18651828
    [Abstract] [Full Text] [Related]

  • 25. Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.
    Traglia M, Girelli D, Biino G, Campostrini N, Corbella M, Sala C, Masciullo C, Viganò F, Buetti I, Pistis G, Cocca M, Camaschella C, Toniolo D.
    J Med Genet; 2011 Sep 17; 48(9):629-34. PubMed ID: 21785125
    [Abstract] [Full Text] [Related]

  • 26. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L, Girelli D, Valenti GF, Castagna A, Como G, Campostrini N, Rametta R, Dongiovanni P, Messa P, Fargion S.
    Clin J Am Soc Nephrol; 2009 Aug 17; 4(8):1331-7. PubMed ID: 19541813
    [Abstract] [Full Text] [Related]

  • 27. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).
    Ong SY, Dolling L, Dixon JL, Nicoll AJ, Gurrin LC, Wolthuizen M, Wood EM, Anderson GJ, Ramm GA, Allen KJ, Olynyk JK, Crawford D, Kava J, Ramm LE, Gow P, Durrant S, Powell LW, Delatycki MB.
    BMJ Open; 2015 Aug 12; 5(8):e008938. PubMed ID: 26270952
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis and treatment of hereditary hemochromatosis: an update.
    Kanwar P, Kowdley KV.
    Expert Rev Gastroenterol Hepatol; 2013 Aug 12; 7(6):517-30. PubMed ID: 23985001
    [Abstract] [Full Text] [Related]

  • 29. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC, Barton JC, Acton RT, So J, Chan S, Adams PC.
    Clin Gastroenterol Hepatol; 2012 Apr 12; 10(4):412-6. PubMed ID: 22265917
    [Abstract] [Full Text] [Related]

  • 30. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ.
    Hum Mol Genet; 2003 Sep 01; 12(17):2241-7. PubMed ID: 12915468
    [Abstract] [Full Text] [Related]

  • 31. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, Motta BM, Bertelli C, Fatta E, Bignamini D, Rametta R, Fargion S, Fracanzani AL.
    Nutr Metab Cardiovasc Dis; 2011 Aug 01; 21(8):568-75. PubMed ID: 20392616
    [Abstract] [Full Text] [Related]

  • 32. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
    Walsh A, Dixon JL, Ramm GA, Hewett DG, Lincoln DJ, Anderson GJ, Subramaniam VN, Dodemaide J, Cavanaugh JA, Bassett ML, Powell LW.
    Clin Gastroenterol Hepatol; 2006 Nov 01; 4(11):1403-10. PubMed ID: 16979952
    [Abstract] [Full Text] [Related]

  • 33. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.
    McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, Krawczak M, Worwood M.
    Gut; 2006 Apr 01; 55(4):554-62. PubMed ID: 16174659
    [Abstract] [Full Text] [Related]

  • 34. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E, Philip J, Lorho R, Ropert M, Latournerie M, Houssel-Debry P, Guyader D, Loréal O, Boudjema K, Brissot P.
    Hepatology; 2014 Mar 01; 59(3):839-47. PubMed ID: 23775519
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW.
    N Engl J Med; 1999 Sep 02; 341(10):718-24. PubMed ID: 10471457
    [Abstract] [Full Text] [Related]

  • 38. [Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
    Bergmans JP, Kemna EH, Janssen MC, Jacobs EM, Stalenhoef AF, Marx JJ, Swinkels DW.
    Ned Tijdschr Geneeskd; 2007 May 19; 151(20):1121-7. PubMed ID: 17557668
    [Abstract] [Full Text] [Related]

  • 39. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC, Wiener HW, Acton RT, Go RC.
    Blood Cells Mol Dis; 2005 May 19; 34(1):38-47. PubMed ID: 15607698
    [Abstract] [Full Text] [Related]

  • 40. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
    Infanti L, Leitner G, Moe MK, Pehlic V, Benkert P, Cattaneo M, Holbro A, Passweg J, Worel N, Buser A.
    Blood Cells Mol Dis; 2022 Nov 19; 97():102689. PubMed ID: 35780678
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.